AIRE Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery time estimates.
Synonyms
AIRE antibody; AIRE_HUMAN antibody; AIRE1 antibody; APECED antibody; APECED protein antibody; APS1 antibody; APSI antibody; Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein antibody; Autoimmune regulator antibody; Autoimmune regulator protein antibody; PGA1 antibody
Target Names
Uniprot No.

Target Background

Function
AIRE, a transcription factor, plays a crucial role in promoting self-tolerance within the thymus. It achieves this by regulating the expression of a wide range of self-antigens, specifically those that are restricted to certain tissues in the periphery, known as tissue-restricted antigens (TRA). AIRE binds to G-doublets within A/T-rich environments, favoring the motif of tandem repeats of 5'-ATTGGTTA-3' coupled with a 5'-TTATTA-3' box. It also binds to nucleosomes and chromatin, exhibiting selective interaction with histone H3 that lacks methylation at 'Lys-4', phosphorylation at 'Thr-3', and methylation at 'Arg-2'. This indicates AIRE's function as a sensor of histone H3 modifications, which are crucial for the epigenetic regulation of gene expression. Primarily expressed by medullary thymic epithelial cells (mTECs), AIRE induces the expression of thousands of tissue-restricted proteins. These proteins are then presented on major histocompatibility complex class I (MHC-I) and MHC-II molecules to developing T-cells traversing the thymic medulla. This process contributes to self-tolerance by enabling the elimination of T-cells that recognize self-antigens. Additionally, AIRE influences self-tolerance through other mechanisms, including the regulation of the mTEC differentiation program. It controls the accumulation of thymic dendritic cells in the medulla and the development of regulatory T-cells through the regulation of XCL1 expression. Furthermore, AIRE regulates the production of CCR4 and CCR7 ligands in medullary thymic epithelial cells, impacting the coordinated maturation and migration of thymocytes. In thymic B-cells, AIRE enables the presentation of licensing-dependent endogenous self-antigen for negative selection. Within secondary lymphoid organs, AIRE induces functional inactivation of CD4(+) T-cells. Finally, AIRE is expressed by a distinct population of bone marrow-derived cells, promoting self-tolerance through a mechanism independent of regulatory T-cells and resistant to innate inflammatory stimuli.
Gene References Into Functions
  1. This review highlights the role of AIRE in peripheral tolerance. PMID: 30255105
  2. AIRE contributes to autoimmunity in more common organ-specific autoimmune disorders than autoimmune polyendocrine syndrome type-1 (Review). PMID: 27504588
  3. The rs3761389 variant is associated with the susceptibility of myasthenia gravis in Chinese patients. PMID: 28262400
  4. Our findings suggest that AIRE does not play a role in the induction and function of monocyte-derived tolerogenic DC in humans; however, this does not exclude a potential role for AIRE in peripheral tolerance mediated by other cell types. PMID: 26912174
  5. Estrogen induces decreased thymic AIRE expression through epigenetic modifications, characterized by an increased number of methylation sites within the AIRE promoter. [review] PMID: 28240208
  6. Whole exome sequencing followed by Sanger sequencing revealed that all three subjects affected by hypoparathyroidism were compound heterozygous for two previously reported mutations, c.967_979delCTGTCCCCTCCGC:p.(L323SfsX51) and c.995+(3_5)delGAGinsTAT, in AIRE. These mutations affect the autoimmune regulator protein encoded by AIRE, which is defective in autoimmune polyglandular syndrome type 1 (APS-1). PMID: 28323927
  7. AIRE exerts multifaceted autoimmune control that extends to a population of innate-like T cells. PMID: 27851927
  8. A homozygous mutation in the AIRE gene is associated with APECED syndrome. PMID: 28222032
  9. The presence of AIRE can trigger molecular events leading to an altered chromatin landscape and the enhanced transcription of low-expressed genes. PMID: 28242760
  10. These data are the first to identify AIRE expression in breast cancer and an association with prognosis. PMID: 27753538
  11. AIRE, phosphorylated on two specific residues near its N terminus, binds to the F-box protein 3 (FBXO3) E3 ubiquitin ligase. This SCF(FBXO3) (SKP1-CUL1-F box) complex then ubiquitylates AIRE, increasing its binding to the positive transcription elongation factor b (P-TEFb), and potentiating its transcriptional activity. PMID: 27365398
  12. This paper shows that genetic polymorphisms in AIRE do not contribute to Graves' disease in Spain. PMID: 27266815
  13. This study supports the notion that AIRE mutation could specifically affect human insulin gene expression in thymic epithelial cells through INS-VNTR and subsequently induce either insulin tolerance or autoimmunity. PMID: 27048654
  14. Androgen control of an intrathymic Aire-mediated tolerance mechanism contributes to gender differences in autoimmunity. PMID: 27072778
  15. Results indicate that in females, estrogen induces epigenetic changes in the AIRE gene, leading to reduced AIRE expression below a threshold that increases female susceptibility to autoimmune diseases. PMID: 26999605
  16. The rs2075876 and rs760426 loci of the AIRE gene are associated with increased risk for rheumatoid arthritis among ethnic Han Chinese from ShaanXi. PMID: 27264825
  17. The novel mutation of c.622G>T (p.G208W) in the AIRE gene is associated with autoimmune polyendocrinopathy syndrome type I. PMID: 26903062
  18. The AIRE-655GAIRE-230T haplotype could dramatically alter AIRE transcription. PMID: 25978041
  19. In the current study, we demonstrate that AIRE activates the expression of transiently transfected luciferase reporters that lack defined promoter regions, as well as intron and poly(A) signal sequences. PMID: 26607109
  20. These results suggest that Aire expression is inherent to all medullary thymic epithelial cells (mTECs) but may occur at particular stage(s) and/or cellular states during their differentiation, thus accounting for the broad impact of Aire on the promiscuous gene expression of mTECs. PMID: 26503950
  21. Keratopathy can be an early and severe manifestation of APS1, significantly affecting the overall prognosis of the disease. Its mechanisms remain to be fully elucidated. PMID: 26114819
  22. Molecular characterization of the functional domains of Aire has revealed multiple binding partners that contribute to Aire's function in altering gene transcription and chromatin remodeling. PMID: 26579596
  23. This study identified a novel AIRE mutation that alters the intracellular location and transcription activity of AIRE, with implications in the pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. PMID: 25064028
  24. Genetic polymorphism is associated with the development and progression of rheumatoid arthritis in China. PMID: 25637666
  25. Data indicate that autoimmune regulator Aire mRNA transcripts are regulated in a keratin 17 (K17) dependent manner in skin tumor keratinocytes. PMID: 26168014
  26. The study reports a new homozygous splicing mutation in the AIRE intron 5 acceptor (c.653-1G>A) in two patients of a consanguineous Spanish family with different phenotypes of autoimmune polyendocrine syndrome type 1. PMID: 24988226
  27. Disease-causing mutations in AIRE are more common than previously appreciated and cause more variable autoimmune phenotypes. PMID: 26084028
  28. Deficiency of AIRE partner, PRKDC, can present as an inflammatory disease with organ-specific autoimmunity, suggesting a role for PRKDC in regulating autoimmune responses and maintaining AIRE-dependent tolerance in human subjects. PMID: 25842288
  29. The disease is caused by a homozygous mutation in the AIRE gene mapped to chromosome 21q22.1. PMID: 25367057
  30. Our findings suggest that the AIRE gene is associated with susceptibility to rheumatoid arthritis in the Spanish population. PMID: 23320549
  31. A model proposes that lysine acetylation enhances the stability of AIRE in the nucleus. PMID: 25158603
  32. Mutations in the AIRE gene are associated with polyglandular autoimmune syndrome type I. PMID: 24945421
  33. APECED was confirmed by molecular analysis of the AIRE gene, which showed two mutations. PMID: 24703644
  34. The findings provide strong evidence for the fundamental role of AIRE and promiscuous gene expression, namely, central tolerance, in the predisposition to autoimmunity of Down syndrome individuals. PMID: 25217160
  35. The increased AIRE gene dose in DS could contribute to an autoimmune phenotype through multiple AIRE-mediated effects on homeostasis and function of thymic epithelial cells, ultimately affecting thymic selection processes. PMID: 25038256
  36. AIRE rs2075876 and rs760426 polymorphisms were involved in the genetic background of rheumatoid arthritis in the Chinese population. PMID: 24170308
  37. These findings implicate AIRE in the promiscuous expression of thyroid proteins in fibrocytes. PMID: 24708100
  38. We demonstrated the importance of Aire's interaction with the ATF7ip-MBD1 protein complex in maintaining central tolerance. PMID: 24464130
  39. Studies indicate that the plant homeodomain 2 (PHD2) of the autoimmune regulator (AIRE) protein plays a critical role in the activation of gene transcription. PMID: 24275490
  40. Eight patients were identified with APECED, and all patients were found to be homozygous for the c.964dell3 mutation. A wide clinical variation is apparent within APECED syndrome. PMID: 23620608
  41. In patients with autoimmune non-APECED polyendocrinopathies, heterozygous mutations of the AIRE gene were not detected; however, a trend of association was observed. Heterozygous polymorphisms S278R and IVS9+6G>A were detected in patients without statistically significant prevalence than in controls. PMID: 23643663
  42. It was concluded that miR-220b inhibited the AIRE gene translation through the 3'UTR region of the AIRE gene, indicating that miR-220b could serve as a regulator for human AIRE gene translation. PMID: 23954874
  43. There are a limited number of cases linking autoimmune retinopathy with a mutation in the AIRE gene. PMID: 23697860
  44. These findings reveal a mutual interdependence of miRNA and Aire in the regulation of promiscuous gene expression in purified mouse and human thymic epithelial cells. PMID: 23589212
  45. Functional characterization of the alternatively spliced AIRE mutation may explain the pathogenetic role in APS-1. PMID: 23342054
  46. Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model. PMID: 23256763
  47. AIRE gene mutations are associated with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy in patients from Apulia and Sicily. PMID: 22104652
  48. [review] The C terminus of AIRE does not share obvious homology with functional domains in other proteins but is highly conserved between human and mouse AIRE proteins, serving as a transcriptional activation domain. PMID: 23456700
  49. Data indicate that the PHD2 domain is required for Aire to interact with a subset of its partners. PMID: 23319629
  50. Mutations in heterozygosity of the AIRE gene are not associated with major findings of autoimmune polyendocrinopathy candidiasis-ectodermal-dystrophy (APECED), also known as autoimmune polyendocrine syndrome type 1. PMID: 22024611

Show More

Hide All

Database Links

HGNC: 360

OMIM: 109100

KEGG: hsa:326

STRING: 9606.ENSP00000291582

UniGene: Hs.129829

Involvement In Disease
Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1)
Subcellular Location
Nucleus. Cytoplasm.
Tissue Specificity
Widely expressed. Expressed at higher level in thymus (medullary epithelial cells and monocyte-dendritic cells), pancreas, adrenal cortex and testis. Expressed at lower level in the spleen, fetal liver and lymph nodes. In secondary lymphoid organs, expres

Q&A

What is the AIRE protein and why is it significant in immunological research?

AIRE (autoimmune regulator) is a critical transcription factor playing an essential role in promoting self-tolerance within the thymus. The protein functions by regulating the expression of tissue-restricted antigens (TRAs) that are typically expressed in peripheral tissues. AIRE binds to G-doublets in A/T-rich environments, with a preferred motif consisting of tandem repeats of 5'-ATTGGTTA-3' combined with a 5'-TTATTA-3' box .

As a sensor of histone H3 modifications, AIRE interacts selectively with histone H3 that lacks specific modifications (methylation at 'Lys-4', phosphorylation at 'Thr-3', and methylation at 'Arg-2') . It is predominantly expressed by medullary thymic epithelial cells (mTECs), where it induces the expression of thousands of tissue-restricted proteins that are presented on MHC-I and MHC-II molecules to developing T-cells. This mechanism is crucial for establishing central tolerance and preventing autoimmune responses .

What are the key differences between various AIRE antibody conjugates available for research?

The AIRE antibodies available for research vary significantly in their host species, isotypes, and conjugate types. For example, the Mouse Monoclonal AIRE antibody (CL488-66262) is derived from Mouse IgG1 and conjugated with CoraLite® Plus 488 Fluorescent Dye, offering excitation/emission maxima at 493 nm/522 nm . This antibody demonstrates reactivity with human and pig samples and is validated for IF/ICC and FC (Intra) applications .

In contrast, the Rabbit Polyclonal AIRE antibody (ab65040) reacts with human samples and is suitable for WB and ICC/IF applications . The difference in host species (mouse versus rabbit) affects the secondary antibody selection in experimental design and may influence specificity and background levels. Researchers should select the appropriate conjugate based on their specific experimental requirements, including microscopy setup, multiplexing needs, and target tissue reactivity.

How does the molecular structure of FITC enable antibody conjugation, and what is the chemical basis for fluorescence?

FITC (fluorescein isothiocyanate) contains an isothiocyanate group (-N=C=S) that reacts covalently with free amino groups (primarily lysine residues) of proteins to form stable thiourea bonds . This reaction forms the chemical basis for antibody labeling. The fluorophore component of FITC has a xanthene structure with conjugated double bonds that absorb light at approximately 495 nm and emit fluorescence at approximately 525 nm .

The quantum efficiency of FITC is relatively high among fluorophores, which contributes to its popularity as a labeling reagent. The fluorescence mechanism involves excitation of electrons to a higher energy state followed by relaxation with emission of lower energy (longer wavelength) photons. It's important to note that the microenvironment around the fluorophore, including pH and protein context, can influence the spectral properties and quantum yield of the conjugate .

What are the optimal conditions for FITC conjugation to AIRE antibodies to maintain immunoreactivity?

The optimal conditions for FITC conjugation to AIRE antibodies involve carefully balancing labeling efficiency with antibody functionality. Research indicates that maximal labeling is achieved when reaction temperature, pH, and protein concentration are all maintained at appropriate levels . Specifically:

  • Temperature: Room temperature (20-25°C)

  • pH: 9.5 (using carbonate-bicarbonate buffer)

  • Protein concentration: 25 mg/ml initial concentration

  • Reaction time: 30-60 minutes

To maintain immunoreactivity, the molar ratio of FITC to antibody should be carefully controlled. Typically, testing different molar ratios (such as 5:1, 10:1, and 20:1 of FITC to IgG) is recommended to determine optimal labeling conditions for specific antibodies . Overlabeling (fluorophore to protein ratios >6) can result in decreased immunoreactivity, increased non-specific binding, and potential aggregation or precipitation of the antibody . The protein solution should be free of amine-containing buffers (such as Tris or glycine) and sodium azide, as these compounds inhibit the labeling reaction .

What are the recommended dilutions and controls for using FITC-conjugated AIRE antibodies in flow cytometry?

Essential controls for flow cytometry experiments include:

  • Unstained cells - to establish autofluorescence baseline

  • Isotype control - a FITC-conjugated antibody of the same isotype (e.g., Mouse IgG1 for CL488-66262) but with irrelevant specificity

  • Single-color controls - when performing multicolor experiments

  • Fixation controls - if fixed cells are used, to account for fixation-induced autofluorescence

  • Blocking controls - to assess and reduce non-specific binding

For intracellular flow cytometry targeting AIRE, proper permeabilization is critical since AIRE is predominantly located in the nucleus. The permeabilization protocol must balance adequate access to the nuclear compartment while preserving epitope structure and fluorophore emission properties .

How do protocols differ for detecting AIRE in different cell types and tissues?

Detection protocols for AIRE must be optimized based on the cell type and tissue being examined due to variations in AIRE expression patterns, cellular localization, and tissue architecture. For cell lines like HeLa, standard immunofluorescence protocols with appropriate permeabilization steps are effective, as demonstrated in validation studies .

For thymic tissues, where AIRE is primarily expressed in medullary thymic epithelial cells (mTECs), more specialized protocols may be required. These often include:

  • Thicker tissue sections (8-10 μm) to capture the scattered mTEC population

  • Enhanced permeabilization steps to access nuclear AIRE

  • Co-staining with epithelial markers (such as cytokeratins) to identify mTECs

  • Longer primary antibody incubation times (overnight at 4°C)

When examining peripheral tissues where AIRE expression may be lower or more restricted, signal amplification methods might be necessary. Additionally, antigen retrieval methods differ between formalin-fixed paraffin-embedded tissues and frozen sections, with the former typically requiring more aggressive epitope unmasking procedures .

How can researchers determine the optimal fluorescein/protein (F/P) ratio for AIRE antibody studies?

Determining the optimal fluorescein/protein (F/P) ratio is critical for balancing signal intensity with antibody functionality. The F/P ratio can be calculated spectrophotometrically by measuring absorbance at 280 nm (protein) and 495 nm (fluorescein) using the following equation:

Molar F/P=2.77×A495A280(0.35×A495)\text{Molar F/P} = \frac{2.77 \times A_{495}}{A_{280} - (0.35 \times A_{495})}

For FITC-IgG conjugates, the optimal F/P ratio typically falls between 2-5. Lower ratios may result in insufficient signal, while higher ratios (>6) can cause increased non-specific binding and fluorophore self-quenching .

To determine the optimal ratio experimentally:

  • Prepare conjugates with different molar ratios (e.g., 5:1, 10:1, and 20:1 of FITC to antibody)

  • Calculate the F/P ratio for each preparation

  • Test each conjugate in your specific application

  • Evaluate signal-to-noise ratio, specificity, and correlation with other detection methods

  • Select the conjugate that provides optimal performance while maintaining low background

For AIRE studies specifically, lower F/P ratios (2-4) often provide better nuclear signal discrimination due to the nuclear localization of the protein and potential high background that can occur with higher labeling densities .

What are common sources of false positives/negatives when using FITC-conjugated AIRE antibodies, and how can they be mitigated?

False results with FITC-conjugated AIRE antibodies can arise from multiple sources:

Sources of false positives:

  • Overlabeling (F/P ratios >6) leading to increased non-specific binding

  • Insufficient blocking of Fc receptors on immune cells

  • Autofluorescence, particularly in tissues rich in elastin or lipofuscin

  • Improper fixation causing antibody trapping

  • Cross-reactivity with similar epitopes in other proteins

Sources of false negatives:

  • Inadequate permeabilization preventing antibody access to nuclear AIRE

  • Epitope masking during fixation

  • Excessive washing reducing signal intensity

  • Photobleaching of FITC during prolonged visualization

  • Suboptimal pH conditions affecting FITC fluorescence

Mitigation strategies:

  • Optimize blocking protocols using species-appropriate sera or commercial blocking reagents

  • Include autofluorescence controls and consider using quenching agents

  • Use proper fixation and permeabilization protocols specific for nuclear antigens

  • Validate antibody specificity using AIRE-deficient controls

  • Maintain pH between 7.2-8.0 during staining and mounting to preserve FITC fluorescence

  • Use antifade mounting media to minimize photobleaching

  • Consider signal amplification techniques for tissues with low AIRE expression

How does photobleaching affect FITC-conjugated antibodies in time-lapse experiments, and what strategies minimize this effect?

FITC is relatively susceptible to photobleaching compared to newer fluorophores, which presents challenges for time-lapse imaging of AIRE dynamics. Under continuous illumination, FITC-conjugated antibodies can lose 5-10% of fluorescence intensity per minute, depending on illumination intensity and environmental conditions.

The photobleaching mechanism involves oxidative damage to the fluorophore structure during the excited state, permanently destroying its fluorescent properties. This effect is particularly problematic when studying nuclear proteins like AIRE that may require higher illumination intensity for clear visualization.

Strategies to minimize photobleaching:

  • Chemical additives:

    • Incorporate anti-fading agents such as p-phenylenediamine or propyl gallate in mounting media

    • Use commercial antifade solutions containing radical scavengers and oxygen-depleting systems

  • Imaging parameters:

    • Reduce excitation light intensity to the minimum required

    • Decrease exposure time and increase camera gain if possible

    • Employ neutral density filters to attenuate excitation light

    • Increase intervals between acquisitions in time-lapse experiments

  • Alternative approaches:

    • Consider switching to more photostable fluorophores (like Alexa Fluor 488) for extended imaging

    • Employ computational correction algorithms to compensate for intensity decay

    • Use specialized microscopy techniques like spinning disk confocal to reduce illumination dose

  • Sample preparation:

    • Ensuring optimal F/P ratios (3-5) to balance signal intensity with photobleaching susceptibility

    • Seal slides completely to prevent oxygen infiltration, which accelerates photobleaching

How can multiplexing with FITC-conjugated AIRE antibodies and other fluorophores be optimized for studying thymic selection mechanisms?

Multiplexing FITC-conjugated AIRE antibodies with other fluorophores enables comprehensive visualization of thymic selection mechanisms by simultaneously detecting multiple markers. To optimize multiplexing experiments:

Fluorophore selection considerations:

  • Choose fluorophores with minimal spectral overlap (FITC pairs well with far-red emitters like Cy5 or Alexa Fluor 647)

  • Consider brightness hierarchy (place dimmer fluorophores on more abundant targets)

  • Account for tissue autofluorescence spectrum when selecting fluorophores

Antibody panel design:

  • Pair AIRE (FITC) with epithelial markers (e.g., cytokeratin-5, CD80) using spectrally distinct fluorophores

  • Include T-cell maturation markers (CD4/CD8) and apoptosis indicators

  • Consider chromatin modification markers to correlate with AIRE binding sites

Technical optimization:

  • Perform sequential staining for certain combinations to avoid steric hindrance

  • Validate each antibody individually before combining

  • Establish proper compensation controls for flow cytometry or spectral unmixing parameters for microscopy

  • Optimize fixation and permeabilization protocols compatible with all target epitopes

Analysis approaches:

  • Employ spatial analysis software to quantify colocalization of AIRE with other nuclear factors

  • Use machine learning algorithms for cell classification in complex tissue architectures

  • Correlate AIRE expression patterns with T-cell selection outcomes using statistical methods

What are the latest methodological advances in studying AIRE-chromatin interactions using fluorescently labeled antibodies?

Recent methodological advances in studying AIRE-chromatin interactions combine fluorescently labeled antibodies with cutting-edge technologies:

Super-resolution microscopy approaches:

  • Structured Illumination Microscopy (SIM) can resolve AIRE nuclear bodies at ~100 nm resolution

  • Stochastic Optical Reconstruction Microscopy (STORM) and Photoactivated Localization Microscopy (PALM) can achieve even higher resolution (~20 nm)

  • These techniques allow visualization of AIRE interaction with specific chromatin domains when combined with appropriate histone modification markers

Proximity ligation assays (PLA):

  • PLA technology using FITC-conjugated detection systems can visualize direct interactions between AIRE and specific histone modifications

  • This approach provides in situ evidence of AIRE's preference for binding to histone H3 lacking specific modifications

Live-cell imaging innovations:

  • Development of photo-switchable FITC derivatives conjugated to AIRE antibody fragments enables pulse-chase experiments

  • New cell-permeable antibody technologies allow tracking AIRE-chromatin dynamics in living thymic epithelial cells

Correlative approaches:

  • Combining immunofluorescence with Chromatin Immunoprecipitation (ChIP-seq) data

  • Integration of spatial transcriptomics with AIRE immunofluorescence to correlate protein localization with gene expression

  • Development of AIRE-specific CUT&Tag protocols using fluorescent antibodies for direct chromatin binding assessment

These methodological advances provide unprecedented insights into how AIRE interacts with chromatin to regulate tissue-restricted antigen expression in the thymus, revealing both global patterns and local dynamics of these interactions .

How can flow cytometric analysis of AIRE be optimized to distinguish between different functional states of thymic epithelial cells?

Optimizing flow cytometric analysis of AIRE to distinguish functional states of thymic epithelial cells requires careful consideration of multiple parameters:

Panel design strategy:

  • Include surface markers for mTEC subpopulations (MHCII, CD80, RANK, CCRL1)

  • Add markers for mTEC maturation stages (Ly51, UEA-1, CD40)

  • Incorporate AIRE (FITC-conjugated) as the key transcription factor

  • Consider including additional transcription factors (FEZF2, FOXN1) with spectrally distinct fluorophores

  • Add functional readouts such as apoptosis markers or cytokine receptors

Sample preparation optimization:

  • Enzymatic digestion protocols must be optimized to preserve epitopes while achieving single-cell suspensions

  • Two-step digestion with collagenase/dispase followed by DNase often yields better results

  • Fixation and permeabilization must be optimized specifically for nuclear transcription factors like AIRE

  • A modified Foxp3 staining buffer system often works well for AIRE detection

Gating strategy refinement:

  • Initial gating on viable EpCAM+ cells to identify epithelial population

  • Further delineation of cortical (Ly51+) versus medullary (UEA-1+) TECs

  • Within mTECs, separate based on MHCII and CD80 expression (mTEClo vs mTEChi)

  • Examine AIRE expression within these subpopulations

  • Correlate AIRE expression with functional markers

Quantitative assessment improvements:

  • Use median fluorescence intensity rather than percent positive for AIRE expression

  • Apply dimensionality reduction techniques (tSNE, UMAP) to identify novel populations

  • Consider cell cycle analysis in conjunction with AIRE expression to identify proliferating subsets

  • Implement standardized calibration beads to ensure reproducibility between experiments

What quality control measures ensure optimal performance of FITC-conjugated AIRE antibodies?

Implementing rigorous quality control measures for FITC-conjugated AIRE antibodies is essential for reliable research outcomes:

Pre-experiment qualification:

  • Determine the fluorescein/protein (F/P) ratio spectrophotometrically using the equation described earlier

  • Optimal F/P ratios for AIRE detection typically range from 2-5; ratios >6 may indicate overlabeling

  • Verify protein concentration post-conjugation to ensure appropriate working dilutions

  • Check for aggregation using dynamic light scattering or size-exclusion chromatography

  • Measure quantum yield if specialized equipment is available

Validation experiments:

  • Perform side-by-side comparison with unconjugated antibody followed by FITC-secondary to verify epitope accessibility

  • Test reactivity on positive control samples (HeLa cells have been verified for many AIRE antibodies)

  • Include known negative controls (AIRE-knockout or knockdown samples)

  • Verify nuclear localization pattern characteristic of AIRE

  • Conduct peptide competition assays to confirm specificity

Storage and handling verification:

  • Check fluorescence intensity after storage to detect potential degradation

  • Monitor pH of storage solution, as FITC fluorescence is pH-sensitive

  • Implement aliquoting strategies to avoid freeze-thaw cycles

  • Store protected from light at -20°C in solution containing 50% glycerol, 0.05% preservative, and stabilizing proteins like BSA

Lot-to-lot consistency assessment:

  • Compare F/P ratios between lots

  • Verify consistent staining patterns with standardized positive controls

  • Consider implementing reference standards for quantitative comparison between experiments

How does fixation and permeabilization methodology affect AIRE epitope detection with FITC-conjugated antibodies?

Fixation and permeabilization methodology significantly impacts AIRE epitope detection due to its nuclear localization and complex structural domains:

Fixation effects:

  • Paraformaldehyde (PFA) fixation (2-4%) generally preserves AIRE epitopes while maintaining cellular architecture

  • Methanol fixation may expose certain epitopes better but can compromise FITC fluorescence

  • Fixation time is critical - excessive fixation can mask epitopes through protein cross-linking

  • Short fixation (10-15 minutes) with 4% PFA often provides optimal results for AIRE detection

Permeabilization considerations:

  • Triton X-100 (0.1-0.5%) provides good nuclear access but may extract some nuclear proteins with extended exposure

  • Saponin (0.1-0.5%) offers milder permeabilization but may be insufficient for complete nuclear access

  • Combined approaches using low concentrations of both detergents can balance accessibility with protein retention

  • For flow cytometry, commercial nuclear transcription factor buffer systems generally provide superior results

Protocol optimization strategies:

  • Test multiple fixation and permeabilization combinations in a matrix format

  • Consider epitope retrieval methods for formalin-fixed tissues (heat-induced or enzymatic)

  • For difficult-to-detect epitopes, try post-fixation permeabilization with methanol at -20°C

  • Verify specific protocol compatibility with fluorophore stability (some harsh permeabilization methods can reduce FITC fluorescence)

Special considerations for AIRE:

  • The specific domain targeted by the antibody affects ideal permeabilization conditions

  • Antibodies targeting the SAND domain or PHD fingers may require more gentle conditions

  • C-terminal epitopes often require more aggressive permeabilization

What considerations are important when designing quantitative experiments using FITC-conjugated AIRE antibodies?

Designing quantitative experiments with FITC-conjugated AIRE antibodies requires attention to several critical factors:

Standardization and calibration:

  • Implement fluorescence calibration beads to convert arbitrary fluorescence units to molecules of equivalent soluble fluorochrome (MESF)

  • Include consistent positive controls across experiments to normalize between sessions

  • Prepare standard curves using known quantities of purified FITC-conjugated antibodies

  • Consider reference standards with defined AIRE expression levels

Technical parameters optimization:

  • Determine linear range of detection for your specific instrument and FITC conjugate

  • Establish appropriate PMT voltages or camera exposure settings that avoid saturation

  • Account for FITC's pH sensitivity by maintaining consistent buffer conditions

  • Implement temperature control during acquisition as fluorescence intensity is temperature-dependent

Experimental design considerations:

  • Include biological replicates (n≥3) to account for natural variation

  • Perform technical replicates to assess methodological reproducibility

  • Include appropriate controls for autofluorescence, non-specific binding, and spectral overlap

  • Design experiments with statistical power in mind, considering effect size and variability

Quantification approaches:

  • For flow cytometry: use median fluorescence intensity rather than mean (less sensitive to outliers)

  • For microscopy: implement automated image analysis algorithms to eliminate observer bias

  • Consider ratio-metric measurements comparing AIRE to a stable nuclear reference protein

  • For population heterogeneity analysis, use dimensionality reduction techniques followed by clustering

Data analysis strategies:

  • Apply appropriate statistical tests based on data distribution (parametric vs. non-parametric)

  • Consider batch effect correction when combining data from multiple experiments

  • Implement hierarchical mixed models for nested experimental designs

  • Use bootstrapping or permutation tests for small sample sizes

How are FITC-conjugated AIRE antibodies being utilized in single-cell technologies to understand thymic selection heterogeneity?

FITC-conjugated AIRE antibodies are increasingly being integrated into advanced single-cell technologies to uncover the heterogeneity of thymic selection processes:

Single-cell flow cytometry applications:

  • Index sorting combined with AIRE detection allows correlation of protein expression with subsequent single-cell gene expression analysis

  • Rare mTEC subpopulations can be identified using high-dimensional flow cytometry incorporating AIRE and up to 30 additional parameters

  • FITC's spectral properties make it compatible with most flow cytometry panels when carefully designed

Single-cell imaging technologies:

  • Imaging mass cytometry incorporates FITC-conjugated AIRE antibodies to map spatial distribution in relationship to developing T-cells

  • Multiplexed ion beam imaging (MIBI) studies use metal-conjugated AIRE antibodies calibrated against FITC standards

  • Cyclic immunofluorescence methods allow visualization of AIRE alongside dozens of other markers on the same tissue section

Integration with genomic approaches:

  • FITC-positive sorted cells can undergo single-cell RNA-seq to correlate AIRE protein levels with gene expression profiles

  • Combined ATAC-seq and AIRE immunophenotyping reveals chromatin accessibility patterns in AIRE-expressing cells

  • Spatial transcriptomics methods correlate AIRE protein localization with tissue-restricted antigen expression in thymic microenvironments

Computational analysis innovations:

  • Machine learning algorithms classify mTEC developmental stages based on AIRE expression patterns

  • Trajectory inference methods incorporate AIRE data to map mTEC maturation pathways

  • Network analysis approaches integrate AIRE expression with cell interaction data to model thymic selection microenvironments

What are the methodological challenges in studying AIRE dynamics in live cells, and how might FITC-conjugated antibodies be adapted for such applications?

Studying AIRE dynamics in live cells presents significant methodological challenges, requiring creative adaptations of FITC-conjugated antibody approaches:

Current limitations:

  • Conventional antibodies don't penetrate live cells with intact membranes

  • Nuclear localization of AIRE complicates accessibility

  • FITC photobleaching limits long-term imaging

  • Potential interference with normal AIRE function upon binding

Innovative adaptation strategies:

  • Cell-permeable antibody fragments:

    • Engineering smaller FITC-conjugated antibody fragments (Fab, scFv, nanobodies)

    • Incorporating cell-penetrating peptides (CPPs) like TAT or Antennapedia

    • Developing pH-sensitive delivery systems that release antibodies in specific cellular compartments

  • Alternative labeling approaches:

    • Combining FITC-antibodies with live-cell permeabilization methods (e.g., streptolysin-O at sublytic concentrations)

    • Using electroporation to deliver FITC-conjugated antibodies while maintaining cell viability

    • Developing antibody-DNA conjugates that can be transfected and expressed intracellularly

  • Technical considerations:

    • Implementing anti-fade systems specific for live-cell applications

    • Using oxygen scavenging systems to reduce photobleaching

    • Employing advanced microscopy techniques that minimize phototoxicity (e.g., lattice light-sheet microscopy)

  • Validation approaches:

    • Correlating live-cell observations with fixed-cell gold standards

    • Implementing controls to confirm antibody specificity in the live-cell context

    • Verifying that antibody binding doesn't disrupt normal protein-protein interactions

While these approaches remain technically challenging, recent advances in antibody engineering and microscopy methods offer promising directions for studying AIRE dynamics in living systems .

How can researchers best integrate data from FITC-conjugated AIRE antibody studies with other omics approaches to understand autoimmune tolerance mechanisms?

Integrating FITC-conjugated AIRE antibody data with other omics approaches creates a comprehensive understanding of autoimmune tolerance mechanisms:

Multi-omic integration strategies:

  • Spatial-omics integration:

    • Overlay AIRE immunofluorescence microscopy with spatial transcriptomics data

    • Create tissue maps linking AIRE protein localization with tissue-restricted antigen expression

    • Develop computational methods to correlate spatial distributions with functional outcomes

  • Flow cytometry-genomics connections:

    • Implement index sorting to link AIRE protein levels with single-cell RNA-seq from the same cells

    • Correlate AIRE expression intensity with chromatin accessibility (scATAC-seq)

    • Develop CITE-seq approaches incorporating AIRE antibodies alongside transcriptome analysis

  • Proteomics connections:

    • Compare AIRE interactome data with AIRE localization patterns

    • Correlate post-translational modifications of AIRE with functional states

    • Link protein expression networks to AIRE-dependent transcriptional programs

Analytical frameworks:

  • Machine learning approaches:

    • Develop supervised learning algorithms to predict AIRE-dependent genes from multi-omic data

    • Implement unsupervised clustering to identify novel cell states related to tolerance induction

    • Use deep learning to integrate image data with molecular profiles

  • Network biology:

    • Construct regulatory networks incorporating AIRE binding data, expression profiles, and protein interactions

    • Identify network motifs associated with robust tolerance induction

    • Model perturbation effects across multi-omic datasets

  • Systems biology modeling:

    • Develop mathematical models of T-cell selection incorporating AIRE expression dynamics

    • Simulate thymic selection processes using multi-scale models from molecular to cellular levels

    • Validate predictions using targeted experiments with FITC-AIRE antibodies

Practical implementation considerations:

  • Standardize data collection procedures across platforms

  • Develop shared metadata structures to facilitate integration

  • Implement robust statistical methods for cross-platform normalization

  • Establish accessible computational pipelines for community use

What are the comparative spectral properties of different fluorescent conjugates for AIRE antibodies?

Understanding the spectral properties of different fluorescent conjugates helps researchers select the optimal fluorophore for specific applications:

Table 7.1: Comparative Spectral Properties of Common Antibody Conjugates

FluorophoreExcitation Max (nm)Emission Max (nm)Quantum YieldBrightnessPhotostabilitypH Sensitivity
FITC4955250.92ModerateLowHigh
CoraLite® 4884935220.85ModerateModerateModerate
Alexa Fluor 4884965190.92HighHighLow
PE5655750.84Very HighModerateLow
APC6506600.68HighHighLow

FITC exhibits strong pH sensitivity, with fluorescence decreasing significantly below pH 7.0. This property requires careful buffer selection for consistent results . CoraLite® 488, used in the CL488-66262 AIRE antibody, provides slightly improved photostability compared to traditional FITC while maintaining similar spectral properties .

For multicolor applications, FITC/CoraLite 488 pairs well with red-emitting fluorophores (PE, APC) but shows significant spectral overlap with TRITC and PE-based tandem dyes. When selecting conjugates for AIRE detection alongside other markers, researchers should consider both instrument capabilities and experimental design to minimize spectral compensation requirements.

What dilution ranges and incubation conditions have been validated for different applications of FITC-conjugated AIRE antibodies?

Proper dilution and incubation conditions are critical for optimal staining results with FITC-conjugated AIRE antibodies:

Table 7.2: Validated Dilution Ranges and Conditions for FITC-Conjugated AIRE Antibodies

ApplicationDilution RangeIncubation TimeTemperatureBuffer SystemSpecial Considerations
Immunofluorescence (IF/ICC)1:50-1:5001-2 hoursRoom temp.PBS + 1% BSAPermeabilization critical for nuclear staining
Flow Cytometry (FC Intra)0.40 μg per 10^6 cells30-45 minutes4°CPBS + 2% FBSSpecialized nuclear fixation buffers recommended
Imaging Flow Cytometry1:100-1:20030-45 minutes4°CPBS + 2% FBSLower concentrations to reduce background
Tissue Immunofluorescence1:20-1:100Overnight4°CPBS + 1% BSA + 0.3% Triton X-100Longer incubation improves penetration
High-resolution Microscopy1:50-1:2002 hoursRoom temp.PBS + 1% BSAExtensive washing required for optimal S/N ratio

For all applications, sample-dependent optimization is recommended, with preliminary titration experiments to determine the optimal antibody concentration for each specific sample type . The incubation conditions should also be optimized based on the specific fixation and permeabilization protocols employed.

For tissue sections, antigen retrieval methods significantly impact the required antibody concentration, with heat-induced epitope retrieval methods often allowing for higher dilutions. The inclusion of background-reducing additives such as normal serum from the same species as the secondary antibody (when applicable) can improve staining specificity .

What are the quantitative aspects of AIRE detection in different cellular contexts?

Understanding the quantitative aspects of AIRE detection across different cellular contexts helps researchers interpret experimental results:

Table 7.3: Quantitative Aspects of AIRE Detection in Different Cellular Systems

Cell/Tissue TypeAIRE Expression LevelSubcellular PatternDetection SensitivityBackground ChallengesSpecial Considerations
Medullary TECs (mTECs)High (in mature mTECs)Nuclear, punctateHighTissue autofluorescenceHeterogeneous expression within population
Cortical TECs (cTECs)Negative/Very lowN/AN/ANon-specific bindingImportant negative control
Thymic Dendritic CellsNegative/Very lowN/AN/AAutofluorescenceHigh autofluorescence requires careful controls
HeLa Cells (experimental)Moderate (when expressed)Nuclear, diffuseModerateLowGood positive control for antibody validation
Peripheral Lymphoid TissuesVery low/Rare cellsNuclearLowHigh tissue autofluorescenceMay require signal amplification
Embryonic ThymusDynamic, developmental-stage dependentNuclearModerateDevelopmental autofluorescenceAge-dependent expression patterns

AIRE expression in medullary thymic epithelial cells (mTECs) exhibits a unique pattern where only approximately 20-30% of the total mTEC population expresses detectable AIRE protein at any given time, creating a mosaic pattern within the thymic medulla. This necessitates appropriate statistical approaches when quantifying AIRE-positive cells within tissues .

For flow cytometric analysis, background fluorescence varies significantly between cell types, with dendritic cells showing particularly high autofluorescence in the FITC channel. This requires careful compensation and gating strategies when analyzing mixed thymic cell populations .

Understanding these quantitative aspects is essential for accurate interpretation of experimental results and appropriate planning of AIRE detection experiments across different biological systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.